| Parameter |
ALCAR group |
Placebo group |
| Number (%) of subjects with HIV-1 viral load <50 cc/ml |
17 (81) |
18 (86) |
| CD4 cell count (median increase per µl, IQR), |
119 (67; 147) |
161 (82;256) |
| MOS-HIV physical health score (median change, IQR) |
0 (-2,1; 4.0) |
0 (-0.9;0.8) |
| MOS-HIV mental score (median change, IQR) |
0.7 (0;0.51) |
0 (-2.1; 5.1) |
| EUROQOL visual analogue scale (median change, IQR) |
0 (-1;15) |
0 (0;13) |
| EUROQOL score (median change, IQR) |
0 (0;0) |
0 (0;0) |
| Number of subjects with lipodystrophy (%) |
4 (22) |
3 (16) |
|
